Breaking News

Piramal Invests $32M to Expand Michigan Facility

Includes additional capacity in Potent and Non-Potent API development and manufacturing.

By: Contract Pharma

Contract Pharma Staff

Piramal Pharma Solutions (PPS) is investing $32 million to expand its facility in Riverview, MI with additional capacity and new capabilities for the development and manufacture of Active Pharmaceutical Ingredients (APIs). The 25,000 sq.-ft. expansion includes 8,500 sq.-ft. of production space, and capacity will increase in large-scale manufacturing with the addition of new reactors capable of handling up to 4000L. PPS is also adding two new kilo labs for process development and GMP manufact...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters